Financials UG Healthcare Corporation Limited

Equities

8K7

SGXE48766716

Medical Equipment, Supplies & Distribution

Market Closed - Singapore S.E. 04:18:26 2024-04-26 am EDT 5-day change 1st Jan Change
0.11 SGD -1.79% Intraday chart for UG Healthcare Corporation Limited 0.00% -34.13%

Valuation

Fiscal Period: Junio 2018 2019 2020 2021 2022 2023
Capitalization 1 44.03 33.05 231.4 354.3 137.2 89.83
Enterprise Value (EV) 1 64.14 66.52 257.7 302.7 55 59.21
P/E ratio 10.2 x 13.3 x 17.4 x 2.96 x 3.71 x -4.33 x
Yield 1.04% 1.58% 0.61% 0.71% 1.45% -
Capitalization / Revenue 0.56 x 0.36 x 1.6 x 1.05 x 0.59 x 0.89 x
EV / Revenue 0.82 x 0.73 x 1.79 x 0.89 x 0.24 x 0.59 x
EV / EBITDA 18.1 x 12.7 x 9.58 x 1.91 x 1.01 x -2.64 x
EV / FCF -8.1 x -4.64 x 27.5 x 6.31 x 4.48 x -2.98 x
FCF Yield -12.4% -21.5% 3.64% 15.9% 22.3% -33.6%
Price to Book 1.05 x 0.78 x 4.43 x 1.86 x 0.6 x 0.5 x
Nbr of stocks (in thousands) 574,380 579,893 588,279 616,259 623,826 623,826
Reference price 2 0.0767 0.0570 0.3933 0.5750 0.2200 0.1440
Announcement Date 10/8/18 10/8/19 10/8/20 10/14/21 10/13/22 10/12/23
1SGD in Million2SGD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Junio 2018 2019 2020 2021 2022 2023
Net sales 1 78.06 91.71 144.2 338.4 232.6 101.1
EBITDA 1 3.552 5.254 26.89 158.3 54.21 -22.41
EBIT 1 2.111 3.631 24.8 155.8 51.17 -25.12
Operating Margin 2.7% 3.96% 17.2% 46.04% 22% -24.84%
Earnings before Tax (EBT) 1 5.047 2.763 18.06 159.4 48.76 -28.36
Net income 1 4.335 2.507 13.4 118.8 36.8 -20.73
Net margin 5.55% 2.73% 9.29% 35.1% 15.82% -20.5%
EPS 2 0.007500 0.004300 0.0226 0.1942 0.0593 -0.0332
Free Cash Flow 1 -7.923 -14.33 9.383 47.99 12.28 -19.89
FCF margin -10.15% -15.63% 6.51% 14.18% 5.28% -19.67%
FCF Conversion (EBITDA) - - 34.89% 30.32% 22.66% -
FCF Conversion (Net income) - - 70.01% 40.41% 33.38% -
Dividend per Share 2 0.000800 0.000900 0.002400 0.004060 0.003200 -
Announcement Date 10/8/18 10/8/19 10/8/20 10/14/21 10/13/22 10/12/23
1SGD in Million2SGD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 20.1 33.5 26.4 - - -
Net Cash position 1 - - - 51.7 82.2 30.6
Leverage (Debt/EBITDA) 5.661 x 6.37 x 0.9802 x - - -
Free Cash Flow 1 -7.92 -14.3 9.38 48 12.3 -19.9
ROE (net income / shareholders' equity) 10.9% 5.2% 30.9% 96.3% 18.5% -13%
ROA (Net income/ Total Assets) 1.74% 2.46% 14.6% 51.1% 11.5% -6.06%
Assets 1 248.8 101.8 91.69 232.6 320.1 342.1
Book Value Per Share 2 0.0700 0.0700 0.0900 0.3100 0.3700 0.2900
Cash Flow per Share 2 0.0100 0.0100 0.0200 0.1100 0.1600 0.1000
Capex 1 4.68 8.53 3.29 18 20.7 7.69
Capex / Sales 5.99% 9.3% 2.28% 5.31% 8.92% 7.6%
Announcement Date 10/8/18 10/8/19 10/8/20 10/14/21 10/13/22 10/12/23
1SGD in Million2SGD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 8K7 Stock
  4. Financials UG Healthcare Corporation Limited